Join
Live feed
·
INSIDERFilingvia Quantisnow
CollPlant Biotechnologies Ltd logo

Deputy CEO and CFO Rotem Eran was granted 510,372 units of Ordinary Shares, increasing direct ownership by 8,506% to 516,372 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CLGN· CollPlant Biotechnologies Ltd
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLGN (CollPlant Biotechnologies Ltd) and more on Quantisnow.